NVST — Envista Holdings Corp stock price, charts and financials

QT65Envista Holdings Corp

Envista Holdings Corp (NYSE: NVST) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.19
+0.04+0.14%
OverviewShort InterestFilings
NVSTQT65Envista Holdings Corp·NYSE
28.19+0.14%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
ICUI-0.12%$184.34MMSI+1.44%$90.32STVN+0.44%$20.36TFX+0.53%$135.70BLCO+0.42%$16.85PLSE-0.99%$41.99XRAY-2.76%$11.79ATR-0.95%$134.14
Snapshot
Index-P/E47.71EPS (ttm)0.59Insider Own1.83%Shs Outstand162.73MPerf Week3.08%
Market Cap4.58BForward P/E17.08EPS next Y1.65Insider Trans-0.19%Shs Float162.02MPerf Month9.28%
Enterprise Value4.58BPEG0.53EPS next Q-Inst Own-Short Float5.78%Perf Quarter15.89%
Income95.28MP/S1.60EPS this Y269.57%Inst Trans-Short Ratio2.99Perf Half Y13.92%
Sales2.86BP/B-EPS next Y8.74%ROA1697307.53%Short Interest9.36MPerf YTD29.66%
Book/sh-P/C15.23EPS next 5Y9.20%ROE4.10%52W High30.46 -7.46%Perf Year42.82%
Cash/sh-P/FCF19.72EPS past 3/5Y-40.66% 1.49%ROIC2381972.73%52W Low18.80 49.97%Perf 3Y-17.01%
Dividend Est.-EV/EBITDA13.04Sales past 3/5Y1.92% 7.11%Gross Margin55.50%Volatility3.79% 3.04%Perf 5Y-34.66%
Dividend TTM-EV/Sales1.60EPS Y/Y TTM106.31%Oper. Margin9.92%ATR (14)0.93Perf 10Y-
Dividend Ex-Date-Quick Ratio2.06Sales Y/Y TTM11.87%Profit Margin3.33%RSI (14)58.72Recom2.68
Dividend Gr. 3/5Y-Current Ratio2.43EPS Q/Q50.00%SMA203.92%Beta0.85Target Price29.14
Payout0.00%Debt/Eq0.52Sales Q/Q14.42%SMA508.63%Rel Volume1.29Prev Close28.15
Employees12,000LT Debt/Eq0.50EarningsNov 04SMA20014.73%Avg Volume3.16MPrice28.19
IPO DateSep 18, 2019Option/ShortYes / YesEPS/Sales Surpr.15.36% 3.74%Net Debt/EBITDA0.00Volume4,070,927Change0.14%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedMorgan StanleyEqual Weight$21 → $23
Aug-06-26ReiteratedRobert W. Baird$31 → $34
Aug-06-26ReiteratedMizuho SecuritiesNeutral$27 → $29
Jul-29-26ReiteratedPiper SandlerNeutral$25 → $26
Jul-08-26InitiatedBMO CapitalMarket Perform$27
Jun-11-26ReiteratedBarclaysOverweight$24 → $32
May-07-26ReiteratedRobert W. Baird$30 → $31
May-07-26ReiteratedEvercore ISI GroupOutperform$30 → $33
Apr-08-26ReiteratedEvercore ISI GroupOutperform$32 → $30
Feb-06-26ReiteratedRobert W. Baird$27 → $30
Latest News
Today
Today10:16AM
Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trendszacks.com
Aug-08-26
Aug-08-2606:05PM
Envista Q2 Earnings Call Highlightsmarketbeat.com
Aug-07-26
Aug-07-2612:41PM
NVST vs. ABT: Which Stock Is the Better Value Option?zacks.com
10:41AM
Here's Why Envista (NVST) is a Strong Value Stockzacks.com
Aug-06-26
Aug-06-2601:50AM
Envista Holdings Corporation (NVST) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-05-26
Aug-05-2610:06PM
Envista (NYSE:NVST) Falls 6% Despite Q2 EPS Beat and Raised GuidanceChartMill
10:01PM
Envista (NVST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com
07:11PM
Envista (NVST) Q2 Earnings and Revenues Surpass Estimateszacks.com
04:05PM
Envista Reports Second Quarter 2026 Resultsprnewswire.com
Jul-30-26
Jul-30-2610:01AM
Envista (NVST) Stock Jumps 5.2%: Will It Continue to Soar?zacks.com
Jul-29-26
Jul-29-2601:17PM
Piper Sandler Maintains Neutral on Envista Holdings, Raises Price Target to $26Benzinga
Jul-28-26
Jul-28-2604:15PM
Envista to Host Investor Day on September 17, 2026prnewswire.com
Jul-17-26
Jul-17-2610:50AM
Envista Holdings Corp (NYSE:NVST) Is a Decent Value Stock with Strong Growth ProspectsChartMill
Jul-14-26
Jul-14-2609:03AM
1 Profitable Stock with Impressive Fundamentals and 2 We QuestionYahoo
Jul-09-26
Jul-09-2611:31AM
Does NVST Stock Still Deserve a Place in Your Portfolio?zacks.com
Company

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,8582,7202,511——————
Cost of Goods Sold Incl. D&A1,2721,2231,119——————
Gross Profit1,5851,4961,392——————
Selling, General and Administrative Excl. Other1,1811,1571,136——————
Research and Development12011499——————
Other Operating Expense101,195——————
Operating Income284226-1,038——————
Interest Expense213746——————
Unusual Expense
—————————
Non-Operating Income (Expense)-29-120——————
Net Income Before Taxes234177-1,085——————
Income Taxes14013034——————
Consolidated Net Income9647-1,119——————
Net Income From Continuing Operations9647-1,119——————
Net Income9647-1,119——————
EPS (Recurring)0.590.28-6.50——————
EPS (Basic, Before Extraordinaries)0.590.28-6.50——————
EPS (Diluted)0.580.28-6.50——————
EBITDA351330280——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio48.6077.54———————
Price To Sales Ratio1.601.341.32——————
Gross Margin55.4655.0055.44——————
Operating Margin9.948.31-41.34——————
Net Margin3.361.73-44.56——————
Shares Outstanding162168172——————
Market Capitalization4,5673,6473,318——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$32.08$28.13$24.18$20.23$16.28● Close Price0.00K81.00K162.00K243.00K324.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Option Exercise17.259,675166,91638,016Feb 11
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Sale30.005,634169,02032,382Feb 11
Reis MischaSVP, Strategy & Bus. Dev.Aug 25 '25Sale21.6015,000324,00032,382Aug 27
Keel Paul AChief Executive OfficerAug 13 '24Buy16.8730,000506,100402,605Aug 14
Hammes Eric D.Chief Financial OfficerAug 12 '24Buy16.3324,532400,60824,532Aug 13
Conley EricSVP, OrthodonticsNov 16 '23Buy22.892,18550,01547,376Nov 20
Nance Mark EGeneral CounselNov 08 '23Buy21.755,000108,75039,042Nov 09
Aghdaei AmirChief Executive OfficerNov 06 '23Buy21.5310,000215,254295,362Nov 07
Keller StephenPrincipal Financial OfficerNov 06 '23Buy21.532,00043,06013,070Nov 07
Yu Howard HChief Financial OfficerFeb 28 '23Sale37.9010,016379,60645,865Mar 01
Yu Howard HChief Financial OfficerNov 17 '22Sale36.5565724,01351,106Nov 21
Yu Howard HChief Financial OfficerApr 18 '22Sale45.735,341244,24452,411Apr 20
Aghdaei AmirChief Executive OfficerMar 29 '22Sale51.503,801195,752364,779Mar 31
Yu Howard HChief Financial OfficerMar 21 '22Option Exercise21.764,786104,14459,682Mar 22
Reis MischaSVP, Strategy & Bus. Dev.Mar 18 '22Sale50.0010,092504,60031,327Mar 22
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.